Skip to main content
. 2017 Aug 8;14(4):3253–3258. doi: 10.3892/etm.2017.4908

Figure 5.

Figure 5.

Expression of miR-186 in (A) tumors, (B) blood and (C) urine samples from patients with bladder cancer. Reverse transcription-quantitative polymerase chain reaction was used to determine the expression of miR-186. Compared with control groups, the expression of miR-186 in tumor tissue, blood and urine samples was significantly downregulated. *P<0.05 and **P<0.01 vs. controls. Data are presented as the mean ± standard deviation. miR, micro RNA.